![](https://www.genosciencepharma.com/wp-content/uploads/2019/11/images.jpg)
17 December 2021
GENOSCIENCE PHARMA out licenses rights of GNS561 in Europe, US and Canada territories in Cholangiocarcinoma
Genoscience is proud to announce the out-licensing of GNS561 in the cholangiocarcinoma in the United…
Read More